KEYNOTE-032: A Randomized Phase I Study of Pembrolizumab in Chinese Patients with Advanced Non-Small Cell Lung Cancer.

Ma, Yuxiang; Fang, Wenfeng; Zhang, Yang; Yang, Yunpeng; Hong, Shaodong; Zhao, Yuanyuan; Xie, Shuang; Ge, Jun; Zhou, HaoJin; Zhao, Hongyun; Zhang, Li

Ma, Yuxiang; Fang, Wenfeng; Zhang, Yang; Yang, Yunpeng; Hong, Shaodong; Zhao, Yuanyuan; Xie, Shuang; Ge, Jun; Zhou, HaoJin; Zhao, Hongyun; Zhang, Li.

Afiliação

Ma Y; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People's Republic of China.
Fang W; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People's Republic of China.
Zhang Y; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People's Republic of China.
Yang Y; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People's Republic of China.
Hong S; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People's Republic of China.
Zhao Y; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People's Republic of China.
Xie S; MSD China, Beijing, People's Republic of China.
Ge J; MSD China, Shanghai, People's Republic of China.
Zhou H; MSD China, Beijing, People's Republic of China.
Zhao H; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People's Republic of China.
Zhang L; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People's Republic of China.

Oncologist ; 25(8): 650-e1145, 2020 08.

Article em En | MEDLINE | ID: mdl-32134163

Assuntos

Carcinoma Pulmonar de Células não Pequenas; Neoplasias Pulmonares; Anticorpos Monoclonais Humanizados; Carcinoma Pulmonar de Células não Pequenas/tratamento farmacológico; China; Humanos; Neoplasias Pulmonares/tratamento farmacológico

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Clinical_trials Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Oncologist Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google